• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9392
Device Problem Failure to Advance (2524)
Patient Problems Thrombosis (2100); Thrombosis/Thrombus (4440)
Event Date 08/28/2020
Event Type  Injury  
Event Description
It was reported that the patient experienced thrombus formation.The target lesion was located in the left anterior descending artery.A 3.0 x 32mm promus element plus drug-eluting stent was selected for use.During the procedure, the stent could not cross the lesion due to the patient experiencing sudden thrombosis.It is unknown what led to the discovery of the thrombosis but it was removed and the procedure was completed with a different device.No further patient complications were reported and the patient was stable post procedure.
 
Event Description
It was reported that the patient experienced thrombus formation.The target lesion was located in the left anterior descending artery.A 3.0 x 32mm promus element plus drug-eluting stent was selected for use.During the procedure, the stent could not cross the lesion due to the patient experiencing sudden thrombosis.It is unknown what led to the discovery of the thrombosis but it was removed and the procedure was completed with a different device.No further patient complications were reported and the patient was stable post procedure.
 
Manufacturer Narrative
Device evaluated by mfr: a promus element plus, mr, ous 3.00x32mm stent delivery system was returned for analysis.A visual examination of the stent found no issues.There was no sign of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal marker bands.The crimped stent outer diameter was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube identified a hypotube kink at 19.6 cm distal from the strain relief.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10571232
MDR Text Key208090522
Report Number2134265-2020-13183
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 05/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/12/2021
Device Model Number9392
Device Catalogue Number9392
Device Lot Number0024003879
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/25/2021
Initial Date Manufacturer Received 08/29/2020
Initial Date FDA Received09/22/2020
Supplement Dates Manufacturer Received04/21/2021
Supplement Dates FDA Received05/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient Weight60
-
-